TAKEDA PHARMACEUTICAL CO LTD(TAK)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

TAKEDA PHARMACEUTICAL CO LTD (TAK) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TAK at 38.1/100 on a 32-signal composite quality model, placing it at rank #2,212 of 2,961 stocks — the bottom half of the AI-ranked universe. Top institutional holders of TAK by reported 13-F value include Capital Research Global Investors, FMR, MORGAN STANLEY, based on the most recent SEC filings. TAK trades on the NYSE exchange and files with the SEC under CIK 1395064. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TAK daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TAKEDA PHARMACEUTICAL CO LTD directly from SEC EDGAR.

AI Quality Score

38.1/100

AI Rank

#2,212

TAK key financials by period

TAKEDA PHARMACEUTICAL CO LTD reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202520-F$4581.6B——
FY 202420-F$4263.8B——
FY 202320-F$4027.5B——
FY 202220-F$3569.0B——
FY 202120-F$3197.8B——
FY 202020-F$3291.2B——

Institutions holding TAK

Institutional investors reporting a position in TAKEDA PHARMACEUTICAL CO LTD on SEC Form 13F.
InstitutionSharesValueReported
Capital Research Global Investors19,297,680$309.3M2026-06-30
FMR9,599,302$153.9M2026-06-30
MORGAN STANLEY6,994,924$112.1M2026-06-30
ADAGE CAPITAL PARTNERS GP, L.L.C.6,050,771$97.0M2026-06-30
GOLDMAN SACHS GROUP5,125,032$82.2M2026-06-30
Pacer Advisors2,515,027$79.7M2026-06-30
BRANDES INVESTMENT PARTNERS4,539,347$72.8M2026-06-30
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP3,732,924$59.8M2026-06-30
BlackRock3,688,166$59.1M2026-06-30
RENAISSANCE TECHNOLOGIES2,568,000$41.2M2026-06-30
SEC EDGAR: CIK 1395064 →
TAK

TAKEDA PHARMACEUTICAL CO LTD

TAK
NYSELarge CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro Quality Score

38.1/100

Rank #2,212 of 2,961 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Top Institutional Holders

as of Q2 2026
$1.78B total
Capital Research Global Investors
$309.34M+1.0%
FMR LLC
$153.88M+34.9%
MORGAN STANLEY
$112.13M+8.1%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$96.99M-5.8%
GOLDMAN SACHS GROUP INC
$82.15M-8.8%
Pacer Advisors, Inc.
$79.74M+6.6%
BRANDES INVESTMENT PARTNERS, LP
$72.77M+2.5%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$59.84M+19.8%
BlackRock, Inc.
$59.12M+16.1%
RENAISSANCE TECHNOLOGIES LLC
$41.17M-14.1%
Loading ratio trend…